Cancer Startup Allogene Makes Trading Debut as Largest Biotech to IPO Since 2009

(Bloomberg) -- Cancer startup Allogene Therapeutics Inc. surged as much as 39 percent above its initial public offering price on its first day of trading in the U.S., after the listing valued the c...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.